Process View
Any process that modulates the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of glomerulus development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| NRP1 | neuropilin 1 | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 1.000 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 1.000 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.999 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.997 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.993 | ||
| PGF | placental growth factor | 0.988 | Human | |
| FSTL1 | follistatin-like 1 | 0.968 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.954 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.927 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.856 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.833 | ||
| NOG | noggin | 0.829 | Mouse | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.770 | Human | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.751 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.715 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.667 | ||
| BMP2 | bone morphogenetic protein 2 | 0.589 | Human | |
| BMP7 | bone morphogenetic protein 7 | 0.560 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.472 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.434 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.380 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.375 | ||
| PDGFC | platelet derived growth factor C | 0.353 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.352 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.342 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.335 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.278 | ||
| STC1 | stanniocalcin 1 | 0.244 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.217 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.195 | ||
| EGR3 | early growth response 3 | 0.195 | ||
| EGR2 | early growth response 2 | 0.180 | ||
| LDLR | low density lipoprotein receptor | 0.147 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.125 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.124 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.106 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.096 | ||
| TAOK1 | TAO kinase 1 | 0.095 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.089 | ||
| THBS1 | thrombospondin 1 | 0.082 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.080 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.074 | ||
| IER2 | immediate early response 2 | 0.073 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.069 | ||
| FST | follistatin | 0.066 | ||
| FOXF1 | forkhead box F1 | 0.057 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.054 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.053 | ||
| BMP4 | bone morphogenetic protein 4 | 0.053 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.047 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.046 | ||
| JUNB | jun B proto-oncogene | 0.045 | ||
| STC2 | stanniocalcin 2 | 0.042 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.041 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.036 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.035 | ||
| ZNF205 | zinc finger protein 205 | 0.035 | ||
| EFNB3 | ephrin-B3 | 0.034 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.033 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.033 | ||
| VEGFC | vascular endothelial growth factor C | 0.033 | Human | |
| NRP2 | neuropilin 2 | 0.032 | ||
| MDFI | MyoD family inhibitor | 0.032 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.031 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.029 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.029 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.029 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.029 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.026 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.026 | ||
| HAND1 | heart and neural crest derivatives expressed 1 | 0.026 | ||
| BMP8B | bone morphogenetic protein 8b | 0.024 | Human | |
| BMP6 | bone morphogenetic protein 6 | 0.024 | Human | |
| BBS4 | Bardet-Biedl syndrome 4 | 0.024 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.023 | ||
| INHBB | inhibin, beta B | 0.023 | ||
| TBX2 | T-box 2 | 0.023 | ||
| WT1 | Wilms tumor 1 | 0.023 | Mouse | |
| TGFB3 | transforming growth factor, beta 3 | 0.022 | ||
| HS3ST2 | heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | 0.022 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.022 | ||
| GFRA1 | GDNF family receptor alpha 1 | 0.022 | ||
| NPM3 | nucleophosmin/nucleoplasmin 3 | 0.021 | ||
| FOXF2 | forkhead box F2 | 0.021 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.021 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.020 | ||
| SLC2A4RG | SLC2A4 regulator | 0.020 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.020 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.020 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.020 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.019 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.019 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.019 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.019 | ||
| EDN1 | endothelin 1 | 0.019 | ||
| GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 0.019 | ||
| ANGPT2 | angiopoietin 2 | 0.018 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.018 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.018 | ||
| PTHLH | parathyroid hormone-like hormone | 0.018 | ||
| HAS2 | hyaluronan synthase 2 | 0.018 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.017 | ||
| BBS2 | Bardet-Biedl syndrome 2 | 0.017 | ||
| BMP3 | bone morphogenetic protein 3 | 0.017 | Human | |
| SOX11 | SRY (sex determining region Y)-box 11 | 0.017 | ||
| TG | thyroglobulin | 0.017 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.017 | ||
| CEP164 | centrosomal protein 164kDa | 0.017 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.017 | ||
| AES | amino-terminal enhancer of split | 0.017 | ||
| IL11 | interleukin 11 | 0.017 | ||
| BBS7 | Bardet-Biedl syndrome 7 | 0.017 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.016 | ||
| NXPH3 | neurexophilin 3 | 0.016 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.016 | ||
| ADCY1 | adenylate cyclase 1 (brain) | 0.016 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.016 | ||
| PITX2 | paired-like homeodomain 2 | 0.016 | ||
| VLDLR | very low density lipoprotein receptor | 0.016 | ||
| G0S2 | G0/G1switch 2 | 0.016 | ||
| MMP19 | matrix metallopeptidase 19 | 0.016 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.016 | ||
| GDNF | glial cell derived neurotrophic factor | 0.016 | ||
| EGFR | epidermal growth factor receptor | 0.015 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.015 | ||
| PRPH | peripherin | 0.015 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.015 | ||
| GPR50 | G protein-coupled receptor 50 | 0.015 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.015 | ||
| SMAD3 | SMAD family member 3 | 0.015 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.015 | ||
| BMP8A | bone morphogenetic protein 8a | 0.014 | Human | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.014 | ||
| PKN1 | protein kinase N1 | 0.014 | ||
| OSMR | oncostatin M receptor | 0.014 | ||
| SOSTDC1 | sclerostin domain containing 1 | 0.014 | ||
| P4HA1 | prolyl 4-hydroxylase, alpha polypeptide I | 0.014 | ||
| FGF4 | fibroblast growth factor 4 | 0.014 | ||
| EXT1 | exostosin 1 | 0.014 | ||
| BTBD2 | BTB (POZ) domain containing 2 | 0.014 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.013 | ||
| ZNF420 | zinc finger protein 420 | 0.013 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.013 | ||
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.013 | ||
| GAS1 | growth arrest-specific 1 | 0.013 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.013 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.013 | ||
| CLSTN2 | calsyntenin 2 | 0.013 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.013 | Human | |
| CDK6 | cyclin-dependent kinase 6 | 0.013 | ||
| PTX3 | pentraxin 3, long | 0.013 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.013 | ||
| RAB3IL1 | RAB3A interacting protein (rabin3)-like 1 | 0.013 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.013 | ||
| GTPBP2 | GTP binding protein 2 | 0.013 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.013 | ||
| GPC3 | glypican 3 | 0.013 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.013 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.013 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.012 | ||
| HOXC10 | homeobox C10 | 0.012 | ||
| SH2B2 | SH2B adaptor protein 2 | 0.012 | ||
| RELN | reelin | 0.012 | ||
| CA9 | carbonic anhydrase IX | 0.012 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.012 | ||
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.012 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.012 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.012 | ||
| INSR | insulin receptor | 0.012 | ||
| UAP1L1 | UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 | 0.012 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.012 | ||
| PRRX1 | paired related homeobox 1 | 0.012 | ||
| EFNB2 | ephrin-B2 | 0.012 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.012 | ||
| JAG1 | jagged 1 | 0.012 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.012 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.012 | ||
| MN1 | meningioma (disrupted in balanced translocation) 1 | 0.012 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.012 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.012 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.012 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.012 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.012 | ||
| PTCH1 | patched 1 | 0.012 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.011 | ||
| ACAN | aggrecan | 0.011 | ||
| RASSF9 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 | 0.011 | ||
| DLK1 | delta-like 1 homolog (Drosophila) | 0.011 | ||
| HOXD10 | homeobox D10 | 0.011 | ||
| HOXD11 | homeobox D11 | 0.011 | ||
| PSG9 | pregnancy specific beta-1-glycoprotein 9 | 0.011 | ||
| NOS1 | nitric oxide synthase 1 (neuronal) | 0.011 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.011 | ||
| YBX2 | Y box binding protein 2 | 0.011 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.011 | ||
| PRPH2 | peripherin 2 (retinal degeneration, slow) | 0.011 | ||
| DLX5 | distal-less homeobox 5 | 0.011 | ||
| NPY5R | neuropeptide Y receptor Y5 | 0.011 | ||
| FGF18 | fibroblast growth factor 18 | 0.011 | ||
| CBX2 | chromobox homolog 2 | 0.011 | ||
| HS3ST3A1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 | 0.011 | ||
| PLXDC1 | plexin domain containing 1 | 0.011 | ||
| NPPC | natriuretic peptide C | 0.011 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.011 | ||
| CHST1 | carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 | 0.011 | ||
| TBX3 | T-box 3 | 0.011 | ||
| GJD2 | gap junction protein, delta 2, 36kDa | 0.011 | ||
| USF2 | upstream transcription factor 2, c-fos interacting | 0.011 | ||
| EYA1 | eyes absent homolog 1 (Drosophila) | 0.011 | ||
| CD34 | CD34 molecule | 0.011 | ||
| ZIC3 | Zic family member 3 (odd-paired homolog, Drosophila) | 0.011 | ||
| PRRX2 | paired related homeobox 2 | 0.011 | ||
| LGALS13 | lectin, galactoside-binding, soluble, 13 | 0.011 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.011 | ||
| SLC16A2 | solute carrier family 16, member 2 (monocarboxylic acid transporter 8) | 0.011 | ||
| CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 | 0.011 | ||
| NODAL | nodal homolog (mouse) | 0.011 | Human | |
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.011 | ||
| HOXB5 | homeobox B5 | 0.010 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.010 | ||
| HHIPL2 | HHIP-like 2 | 0.010 | ||
| ACVR2B | activin A receptor, type IIB | 0.010 | ||
| TSHB | thyroid stimulating hormone, beta | 0.010 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.010 | ||
| CARD10 | caspase recruitment domain family, member 10 | 0.010 | ||
| HOXC5 | homeobox C5 | 0.010 | ||
| AVPR1A | arginine vasopressin receptor 1A | 0.010 | ||
| AR | androgen receptor | 0.010 | ||
| PLAT | plasminogen activator, tissue | 0.010 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.010 | ||
| USP42 | ubiquitin specific peptidase 42 | 0.010 | ||
| NKX3-2 | NK3 homeobox 2 | 0.010 | ||
| NTN1 | netrin 1 | 0.010 | ||
| INHBA | inhibin, beta A | 0.010 | ||
| SCUBE3 | signal peptide, CUB domain, EGF-like 3 | 0.010 | ||
| KCNC4 | potassium voltage-gated channel, Shaw-related subfamily, member 4 | 0.010 | ||
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.010 | ||
| ULBP2 | UL16 binding protein 2 | 0.010 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.010 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.010 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.010 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.010 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.010 | ||
| CER1 | cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis) | 0.010 | ||
| ADAM18 | ADAM metallopeptidase domain 18 | 0.010 | ||
| EN2 | engrailed homeobox 2 | 0.010 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.010 | ||
| PAX7 | paired box 7 | 0.010 |